Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Election Fraction

被引:28
|
作者
Regan, Jessica A. [1 ]
Kitzman, Dalane W. [2 ]
Leifer, Eric S. [3 ]
Kraus, William E. [1 ,7 ]
Fleg, Jerome L. [3 ]
Forman, Daniel E. [4 ,5 ]
Whellan, David J. [6 ]
Wojdyla, Daniel [7 ]
Parikh, Kishan [1 ,7 ]
O'Connor, Christopher M. [8 ]
Mentz, Robert J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[2] Wake Forest Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA
[3] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[6] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[7] Duke Clin Res Inst, Durham, NC USA
[8] Inova Heart & Vasc Inst, Falls Church, VA USA
基金
美国国家卫生研究院;
关键词
age; body mass index; comorbidities; depression; heart failure with reduced ejection fraction; HF-ACTION; NONCARDIAC COMORBIDITIES; EJECTION FRACTION; OBESITY PARADOX; CO-MORBIDITIES; OLDER-ADULTS; DEPRESSION; MORTALITY; RISK; MULTIMORBIDITY;
D O I
10.1016/j.jchf.2019.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine whether age modifies the impact of key comorbidities on clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF). BACKGROUND Comorbidities impact outcomes in HFrEF. However, the effect of age on the impact of comorbidities on prognosis is not clearly understood. METHODS Cox proportional hazards models were used assessed interactions between age and comorbidities on the primary composite endpoint (all-cause mortality or hospitalization) and secondary endpoints in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) multicenter trial of 2,331 patients with HFrEF. RESULTS Age did not significantly modify the effect of any comorbidity on the primary endpoint. However, age significantly modified the effect of body mass index (BMI) on all-cause mortality (interaction p = 0.02). Among patients >= 70 years of age, there was a U-shaped relationship between BMI and 1-year mortality, where BMI of 20 kg/m(2) corresponded to 17.6%; a BMI of 30 kg/m(2) corresponded to 7.0%; and a BMI of 40 kg/m(2) corresponded to 11%. For patients <60 years of age, mortality increased nonsignificantly from 3.2% to 3.7% with increasing BMI. Age also modified the effect of depressive symptoms on alt-cause mortality (interaction p = 0.03). Among patients >= 70 years of age, a 1-year mortality rate significantly increased from 7.8% for a Beck Depression Inventory (BOO score of 5% to 15.6% for BIN of 20. For patients <60 years of age, mortality was nonsignificantly related to BDI. Cumulative comorbidity scores were stronger predictors than age for mortality/hospitalization. CONCLUSIONS hi chronic HFrEF, age markedly altered the impact of BMI and depressive symptoms on all-cause mortality, with much higher risk in older patients, but was not as strong a predictor of mortality/hospitalizations as cumulative comorbidity score. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:1056 / 1065
页数:10
相关论文
共 50 条
  • [1] Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction
    Reinhardt, Marielen
    Schupp, Tobias
    Behnes, Michael
    Lau, Felix
    Schmitt, Alexander
    Abel, Noah
    Akin, Muharrem
    Rusnak, Jonas
    Akin, Ibrahim
    Weidner, Kathrin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [2] Depressive symptoms are associated with clinical outcomes in heart failure with reduced ejection fraction
    Sherwood, Andrew
    Blumenthal, James A.
    Mentz, Robert J.
    Koch, Gary G.
    Rogers, Joseph G.
    Chang, Patricia P.
    Chien, Christopher
    Adams, Kirkwood F.
    Rose-Jones, Lisa J.
    Jensen, Brian C.
    Donahue, Mark
    Johnson, Kristy S.
    Hinderliter, Alan L.
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
  • [3] Age, Sex, and Outcomes in Heart Failure With Reduced EF
    Lam, Carolyn S. P.
    Pina, Ileana L.
    Zheng, Yinggan
    Bonderman, Diana
    Pouleur, Anne-Catherine
    Saldarriaga, Clara
    Pieske, Burkert
    Blaustein, Robert O.
    Nkulikiyinka, Richard
    Westerhout, Cynthia M.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2023, 11 (09) : 1246 - 1257
  • [4] Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
    Edelmann, Frank
    Stahrenberg, Raoul
    Gelbrich, Goetz
    Durstewitz, Kathleen
    Angermann, Christiane E.
    Duengen, Hans-Dirk
    Scheffold, Thomas
    Zugck, Christian
    Maisch, Bernhard
    Regitz-Zagrosek, Vera
    Hasenfuss, Gerd
    Pieske, Burkert M.
    Wachter, Rolf
    CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (09) : 755 - 764
  • [5] Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
    Lin, Tin-Kwang
    Hsu, Bo-Cheng
    Li, Yi-Da
    Chen, Chi-Hsien
    Lin, Jiunn-Wen
    Chien, Chen-Yu
    Weng, Chia-Ying
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (12):
  • [6] Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced
    Filippatos, Gerasimos
    Anker, Stefan D.
    Butler, Javed
    Farmakis, Dimitrios
    Ferreira, Joao Pedro
    Gollop, Nicholas D.
    Brueckmann, Martina
    Iwata, Tomoko
    Pocock, Stuart
    Zannad, Faiez
    Packer, Milton
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2297 - 2304
  • [7] Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure
    Bencivenga, Leonardo
    Komici, Klara
    Femminella, Grazia Daniela
    Paolillo, Stefania
    Gargiulo, Paola
    Formisano, Roberto
    Assante, Roberta
    Nappi, Carmela
    Puzone, Brunella
    Sepe, Immacolata
    Cittadini, Antonio
    Vitale, Dino Franco
    Ferrara, Nicola
    Cuocolo, Alberto
    Filardi, Pasquale Perrone
    Rengo, Giuseppe
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 86 : 86 - 90
  • [8] Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
    Streng, Koen W.
    Nauta, Jan F.
    Hillege, Hans L.
    Anker, Stefan D.
    Cleland, John G.
    Dickstein, Kenneth
    Filippatos, Gerasimos
    Lang, Chim C.
    Metra, Marco
    Ng, Leong L.
    Ponikowski, Piotr
    Samani, Nilesh J.
    van Veldhuisen, Dirk J.
    Zwinderman, Aeilko H.
    Zannad, Faiez
    Damman, Kevin
    van der Meer, Peter
    Voors, Adriaan A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 271 : 132 - 139
  • [9] Prognostic Impact of Comorbidities on Mortality in Patients with Heart failure and Preserved Ejection Fraction vs Heart Failure with Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Deswal, Anita
    CIRCULATION, 2010, 122 (21)
  • [10] Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Zachariah, Amit A.
    Wehrens, Xander H. T.
    Deswal, Anita
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 998 - 1005